Bladder Cancer and Prostatic Cancer

Slides:



Advertisements
Similar presentations
Investigation and Management of Prostate Cancer
Advertisements

Diagnosis.
Is Radical Prostatectomy Adequate For High Risk Prostate Cancer?
PROSTATE CANCER Dr Samad Zare Assistant Proffesor of Urology Shaheed Sadoughi University of Medical Sciences.
Advanced Stage Prostate Cancer Management Michael E. Karellas Assistant Professor of Urologic Oncology May 15, 2010.
Management of locally advanced & metastatic prostate cancer Dr. Purvish. M. Parikh MD, DNB, PhD, FICP Professor & Head Department of Medical Oncology Tata.
British Association of Urological Surgeons Metastatic Prostate Cancer Guidelines.
In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.
Radiotherapy in prostate cancer Dr.Mina Tajvidi Radiation oncologist.
PROSTATE CANCER EXPECTED MANAGEMENT & CURATIVE TREATMENT Dr. Abdullah A. Ghazi (R5) KSMC.
Steven Joniau Filip Ameye
Prostate Radiotherapy A-Z
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Prostate Cancer Int. 洪 毓 謙. Prostate cancer is the Second leading cause of death from cancer in the United States American male, the lifetime risk of:
Controversies in the management of PSA-only recurrent disease Stephen J. Freedland, MD Associate Professor of Urology and Pathology Durham VA Medical Center.
Akbar Ashrafi Surgical Students Society of Melbourne September 2010.
Treatment options for locally recurrent Prostate Cancer Giuseppe Simone Mediterranean School of Oncology Roma
In the name of God Isfahan medical school Shahnaz Aram MD.
Howard M. Sandler, MD University of Michigan Medical School
Prostate Cancer Case Presentation Shireen Siddiqui.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Breast Cancer: The Profile Ma. Belen E. Tamayo,M.D. Medical Oncologist Makati Medical Center The Medical City.
 General recommendations -adjuvant systemic therapy :with tamoxifen or multiple-chemotherapy agent :lower the incidence of recurrence by about 30% - in.
Prostate Cancer Treatment: What’s Best For You?
TREATMENT Mastectomy -traditionally, treatment of breast ca has been surgical -19 century, surgical treatment : local excision ~ total mastectomy : radical.
PROSTATE CANCER: RADIATION APPROACHES for advanced disease
Bladder cancer is the second most common cancer of the genitourinary tract. The incidence is higher in whites than in African Americans. The average age.
H. Emama M.D.. (Radiation Therapy) By: H. Emami Assistant professor of Radiation Oncology, Isfahan University of Medical Sciences, Isfahan, IRAN.
CASE 1 65-year-old man No other diseases or previous surgeries July 2005: PSA 11.5 ng/ml; F/T: 9% After prostate biopsy revealing adenocarcinoma: RETROPUBIC.
Neoplasms of the bladder
Protocols for Advanced Prostate Cancer and/or Local Failure After Radical Prostatectomy Isaac Powell, MD.
LCC REC-1 Φ π π π Φ Φ See Primary and Adjuvant Treatment (LCC REC-3) Observe or See Primary Treatment (LCC REC-3) Rectal Cancer.
TNM Staging: Prostate TONYA BRANDENBURG, MHA, CTR KENTUCKY CANCER REGISTRY.
LCC COL-1 See Pathologic Stage, Adjuvant Therapy, and Surveillance (LCC COL-3) Φ Φ Φ π π π Colon Cancer.
Carcinoma of the prostate. INTRODUCTION Prostate cancer is the most common cancer diagnosed and is the second leading cause of cancer death in men in.
Prostate Cancer David Eedes 11 May Prostate Cancer Definition: Prostate cancer is a disease in which cells in the prostate gland become abnormal.
Professor Guram Karazanashvili MD, KMSc, DMSc MMT Hospital.
Bladder Cancer R. Zenhäusern.
Carcinoma of Prostate Issam S. Al-Azzawi, MD,FICMS,FEBU By
Carcinoma of the prostate
Nasopharyngeal carcinoma
Dr Amit Gupta Associate Professor Dept Of Surgery
Results of Definitive Radiotherapy in Anal Canal Carcinoma
Surgical Treatment in Locally Advanced Prostate Cancer
Professor Guram Karazanashvili MD, KMSc, DMSc MMT Hospital
Updates in Prostate Cancer Prepared for GP master class – Sept 2016
Prostate cancer นพ.ชัชชัย หอมเกตุ.
Post Op Positive Apex Margins Case 3: Prostate_3
Nat. Rev. Urol. doi: /nrurol
Management of Invasive Bladder Cancer
Decipher Prostate, Decipher Bladder and Decipher GRID
The Role of Radical Prostatectomy and Radiotherapy in Treatment of Locally Advanced Prostate Cancer: A Systematic Review and Meta-Analysis Urol Int 2017;99:
Institute of Oncology “Ion Chiricuță”, Cluj, Romania
RTOG 0126 A Phase III Randomized Study of High Dose 3D-CRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer Bijoy.
أجهزة العلاج الإشعاعي Clinical Radiation Generator
Post Op Positive Seminal Vesicle Case 4: Prostate_4
N.N. Alexandrov National Cancer Centre
Prostate Cancer: Highlights from 2006
Radiotherapy for Metastatic Spinal Cord Compression
Apollo Gleneagles Hospitals,
Advances in the Treatment of Metastatic Prostate Cancer
What is New in Hormone Therapy for Prostate Cancer in 2007?
Current Guidelines in the treatment of Prostate Cancer: what is most appropriate for Nigerian patients? Dr Emmanuel Ajibola Jeje BSc. M. B. Ch.B; FMCS;
Nat. Rev. Urol. doi: /nrurol
External Beam Radiotherapy as Curative Treatment of Prostate Cancer
Antonio Alcaraz, Pierre Teillac  European Urology Supplements 
Neoadjuvant Adjuvant Curative Palliative
Prostate Cancer Update
Fernando P. Secin, Fernando J. Bianco, Nicholas T
General strategies of Cancer Treatment and evaluation of Response
Presentation transcript:

Bladder Cancer and Prostatic Cancer CA PROSTAE AND BLDDER Bladder Cancer and Prostatic Cancer

Each cancer will be discussed by three specialists -Surgeon -Radiation Oncologist -Medical Oncologist Followed by Question

Definite Radiotherapy for Prostate Cancer Localize early prostate cancer - Very low Risk with life expectancy > 20 years ( Age < 62 ) - Low Risk with life expectancy > 10 years ( Age < 77 ) Locally advance prostate cancer - Intermediate / high risk / very high risk ( Including pelvic LN metastatic without distant metastasis ) Radiotherapy with LHRH agonist

Adjuvant / Salvage Radiotherapy after Radical Prostatectomy Extra-capsular Extension / Positive margins / Extension to seminal vesicle or Post-operative case with PSA > 0.2 ng/ml or มีการเพิ่มของ PSA หลังการผ่าตัดอย่างต่อเนื่องและมีนัยสำคัญ

Palliative Radiotherapy in Prostate Cancer For Pain, Bleeding, Bone mets, Brain Mets, Spinal cord compression, etc. for Advance or Metastases Disease

High Dose Rate Radiotherapy In Intermediate and High risk group as Booster dose to External Radiotherapy As monotherapy instead of low dose rate radiotherapy in low risk or selected intermediate risk group In recurrent tumor after radiotherapy

Hormonal treatment in combination with Radiotherapy LHRH Agonist not more than Two cycles: In Intermediate risk prostate cancer stage cT2B and cT2C and/or Gleason score 7 and/or PSA 10-20 ng/ml LHRH agonist not more than Eight cycles: In High risk group stage cT3A and/or Gleason score 7-10 and/or PSA >20 ng/ma, or In Very high risk group stage cT3B and cT4

Bladder Preservation Therapy ( Maximal TURBT followed by Concurrent Chemo-Radiotherapy ) Indication Clinical stage T2-4, N any, M0 Single lesion No hydro-nephrosis is preferred Tumor size < 5.0 cm is preferred No extensive TIS

Primary Radiotherapy for Bladder Cancer in muscle invasive pT3-4 or pN+ In case of very Old age and Medical contraindication May consider Concurrent Chemo-Radiotherapy or Radiotherapy alone depending on the patient status

Adjuvant Radiotherapy after Cystectomy In patient who can not tolerate chemotherapy after partial or total cystectomy May consider in Positive margin or pT3-4 tumor or N +ve or high grade

Palliative Radiotherapy For Pain, Bleeding, Bone mets, Brain Mets, Spinal cord compression, etc. for Advance or Metastases Disease